BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28867190)

  • 1. Modulation of RAB5A early endosome trafficking in response to KRas mediated macropinocytic fluxes in pancreatic cancer cells.
    Teske C; Schweitzer C; Palamidessi A; Aust DE; Scita G; Weitz J; Welsch T
    Biochem Biophys Res Commun; 2017 Nov; 493(1):528-533. PubMed ID: 28867190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of rab5 activation in endocytosis and phagocytosis.
    Roberts RL; Barbieri MA; Ullrich J; Stahl PD
    J Leukoc Biol; 2000 Nov; 68(5):627-32. PubMed ID: 11073100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL4/PGE2 induction of an enlarged early endosomal compartment in mouse macrophages is Rab5-dependent.
    Wainszelbaum MJ; Proctor BM; Pontow SE; Stahl PD; Barbieri MA
    Exp Cell Res; 2006 Jul; 312(12):2238-51. PubMed ID: 16650848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic Acid Inhibits
    Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome proteins are redistributed during expression of a GTP-hydrolysis-defective rab5a.
    Rosenfeld JL; Moore RH; Zimmer KP; Alpizar-Foster E; Dai W; Zarka MN; Knoll BJ
    J Cell Sci; 2001 Dec; 114(Pt 24):4499-508. PubMed ID: 11792815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer.
    Xiong X; Rao G; Roy RV; Zhang Y; Means N; Dey A; Tsaliki M; Saha S; Bhattacharyya S; Dhar Dwivedi SK; Rao CV; McCormick DJ; Dhanasekaran D; Ding K; Gillies E; Zhang M; Yang D; Bhattacharya R; Mukherjee P
    FASEB J; 2020 Sep; 34(9):12024-12039. PubMed ID: 32692445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters.
    Kanaani J; Diacovo MJ; El-Husseini Ael-D; Bredt DS; Baekkeskov S
    J Cell Sci; 2004 Apr; 117(Pt 10):2001-13. PubMed ID: 15039456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani resides in modified early endosomes by upregulating Rab5a expression via the downregulation of miR-494.
    Verma JK; Rastogi R; Mukhopadhyay A
    PLoS Pathog; 2017 Jun; 13(6):e1006459. PubMed ID: 28650977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
    Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
    Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
    Jin X; Sun Y; Yang H; Li J; Yu S; Chang X; Lu Z; Chen J
    PLoS One; 2015; 10(4):e0125515. PubMed ID: 25905463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
    Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs.
    Liu H; Sun M; Liu Z; Kong C; Kong W; Ye J; Gong J; Huang DCS; Qian F
    J Control Release; 2019 Feb; 296():40-53. PubMed ID: 30653981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer.
    Azizan N; Suter MA; Liu Y; Logsdon CD
    Biochem Biophys Res Commun; 2017 Nov; 493(1):592-597. PubMed ID: 28867179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Listeria monocytogenes protein interfering with Rab5a.
    Alvarez-Dominguez C; Madrazo-Toca F; Fernandez-Prieto L; Vandekerckhove J; Pareja E; Tobes R; Gomez-Lopez MT; Del Cerro-Vadillo E; Fresno M; Leyva-Cobián F; Carrasco-Marín E
    Traffic; 2008 Mar; 9(3):325-37. PubMed ID: 18088303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for EHD4 in the regulation of early endosomal transport.
    Sharma M; Naslavsky N; Caplan S
    Traffic; 2008 Jun; 9(6):995-1018. PubMed ID: 18331452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
    Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
    Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
    Raho S; Capobianco L; Malivindi R; Vozza A; Piazzolla C; De Leonardis F; Gorgoglione R; Scarcia P; Pezzuto F; Agrimi G; Barile SN; Pisano I; Reshkin SJ; Greco MR; Cardone RA; Rago V; Li Y; Marobbio CMT; Sommergruber W; Riley CL; Lasorsa FM; Mills E; Vegliante MC; De Benedetto GE; Fratantonio D; Palmieri L; Dolce V; Fiermonte G
    Nat Metab; 2020 Dec; 2(12):1373-1381. PubMed ID: 33230296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
    Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
    Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.